Evidence map›Paper›PMID 37915705›Full record

ArticleAnnals of medicine and surgery (2012)2023

Long-term cognitive dysfunction after the COVID-19 pandemic: a narrative review.

Sanobar Shariff, Olivier Uwishema, Jocelyn Mizero, Vimala Devi Thambi, Abubakar Nazir, Ashraf Mahmoud, Ikshwaki Kaushik, Saadeddine Khayat, Abdulkadir Yusif Maigoro, Sara Awde and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 11 countries.

Sanobar ShariffOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Olivier UwishemaOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Jocelyn MizeroOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Vimala Devi ThambiOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Abubakar NazirOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Ashraf MahmoudOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Ikshwaki KaushikOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Saadeddine KhayatOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Abdulkadir Yusif MaigoroOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Sara AwdeOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Zeina Al MaazOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Iktimal AlwanOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Mahdi HijaziOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Jack WellingtonOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Lee SoojinOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Rwanda Meteorological Service · RWBeirut Arab University · LBChungnam National University · KRClinton Foundation · USKilimanjaro Christian Medical Centre · TZKing Edward Medical University · PKUniversity of Ghana · GHYerevan State Medical University · AM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has brought a conglomerate of novel chronic disabling conditions described as 'Long COVID/Post-COVID-19 Syndrome'. Recent evidence suggests that the multifaceted nature of this syndrome results in both pulmonary and extrapulmonary sequelae,chronic dyspnoea, persistent fatigue, and cognitive dysfunction being the most common, debilitating symptoms. Several mechanisms engender or exacerbate cognitive impairment, including central nervous system and extra-central nervous system causes, although the exact mechanism remains unclear. Both hospitalized and non-hospitalized patients may suffer varying degrees of cognitive impairment, ranging from fatigue and brain fog to prolonged deficits in memory and attention, detrimental to the quality-of-life years post-recovery. The aim of this review is to understand the underlying mechanisms, associations, and attempts for prevention with early intervention of long-term cognitive impairment post-COVID-19. Methodology: A systematic search was conducted through multiple databases such as Medline, National Library of Medicine, Ovid, Scopus database to retrieve all the articles on the long-term sequalae of cognitive dysfunction after SARS-CoV-2 infection. The inclusion criteria included all articles pertinent to this specific topic and exclusion criteria subtracted studies pertaining to other aetiologies of cognitive dysfunction. This search was carefully screened for duplicates and the relevant information was extracted and analysed. Results/discussion: To date, the exact pathogenesis, and underlying mechanisms behind cognitive dysfunction in COVID-19, remain unclear, hindering the development of adequate management strategies. However, the proposed mechanisms suggested by various studies include direct damage to the blood-brain barrier, systemic inflammation, prolonged hypoxia, and extended intensive care admissions. However, no clear-cut guidelines for management are apparent. Conclusion: This review of the COVID-19 pandemic has elucidated a new global challenge which is affecting individuals' quality of life by inducing long-term impaired cognitive function. The authors have found that comprehensive evaluations and interventions are crucial to address the cognitive sequelae in all COVID-19 patients, especially in patients with pre-existing cognitive impairment. Nevertheless, the authors recommend further research for the development of relevant, timely neurocognitive assessments and treatment plans.

Indexed as

Braincognitive dysfunctioncoronavirusCOVID-19

Identifiers

PMID37915705
PMCPMC10617879
OpenAlexW4386600152

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.